Chronic kidney disease (CKD) is extremely prevalent among adults, affecting over 800 million individuals worldwide.
FDA grants ODD to Abdera’s neuroendocrine carcinoma treatment
The biologic therapy is created to deliver the radioisotope 225Ac to tumours expressing the DLL3 protein. Credit: Kateryna Kon/Shutterstock. The US Food and Drug Administration